🔎 Trials Near Me

Hjem › KOL › Florida › Miami

KOL kliniske forsøg i Miami, FL

18 studier for KOL søger deltagere på steder i og omkring Miami (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

RekruttererFase 3
  • Research Site, Miami
  • Research Site, Miami
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Elite Clinical Research - Miami- Site Number : 8400167, Miami
  • DL Research Solutions- Site Number : 8400140, Miami
  • Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
  • og 3 flere
Alder 40 til 80 · Alle køn · Opdateret 1. okt. 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

RekruttererFase 2
  • Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
Alder 40 til 85 · Alle køn · Opdateret 30. sep. 2026 · NCT07684820

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

RekruttererFase 3
  • GSK Investigational Site, Miami
Alder 40 til 80 · Alle køn · Opdateret 25. sep. 2026 · NCT07780656

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

RekruttererFase 2
  • Millennium Medical Research - Miami, Miami
Alder 40 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
  • MCR Research- Site Number : 8400004, Miami
  • Nuren Medical & Research Center- Site Number : 8400030, Miami
  • og 1 flere
Alder 40 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07190209

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

RekruttererFase 4
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
Alder 40 til 85 · Alle køn · Opdateret 22. sep. 2026 · NCT07053423

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
  • og 2 flere
Alder 40 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RekruttererFase 3
  • Research Site, Miami
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RekruttererFase 3
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2/3
  • Reed Medical Research, Miami
Alder 35 til 80 · Alle køn · Opdateret 31. aug. 2026 · NCT07363694

Rademikibart IV for Acute Asthma and COPD Exacerbation

RekruttererFase 2
  • Columbus Clinical Services, LLC, Miami
  • Pharmax Research of South Florida, Inc., Miami
Alder 18 til 85 · Alle køn · Opdateret 27. aug. 2026 · NCT07705737

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RekruttererFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Alder 40 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

Rekrutterer
  • University of Miami, Miami
Alder 18 til 100 · Alle køn · Opdateret 22. jun. 2026 · NCT06578156

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RekruttererFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • og 4 flere
Alder 40 til 80 · Alle køn · Opdateret 9. apr. 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

RekruttererFase 3
  • GSK Investigational Site, Miami
Alder 40 til 80 · Alle køn · Opdateret 8. okt. 2025 · NCT06959095

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Rekrutterer
  • Reliable Research, Inc., Miami
  • NewGen Health Group, Miami
Alder 30 og opefter · Alle køn · Opdateret 6. feb. 2025 · NCT05204888

KOL forsøg i andre byer

Andre studier i Miami

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.